Search

everythinglearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Origanum vulgare leaf extract reduces liver and kidney damage caused by finasteride in mice.

PRP can help regrow hair in people with alopecia.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Polydopamine is a safe, effective, and permanent hair dye that turns gray hair black in one hour.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Vitamin B12 may promote hair growth by affecting certain cell processes.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Fat cells in the skin help start healing and form important repair cells after injury.

Many popular skincare products claim to prevent aging but lack strong evidence to prove their effectiveness and safety.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

White blood cells and their traps can slow down the process of new hair growth after a wound.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

The model and estimator can predict drug exposure in kidney transplant patients well.

The skin acts like an endocrine organ, producing hormones that affect various body functions and skin health, and understanding this can lead to new treatments.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Tofacitinib may help treat severe hair loss, but more research is needed.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Erdr1 could be a new marker for diagnosing hair loss.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.